146 related articles for article (PubMed ID: 10925100)
21. Posterior urethral valves in Eastern Ontario - a 30 year perspective.
Warren J; Pike JG; Leonard MP
Can J Urol; 2004 Apr; 11(2):2210-5. PubMed ID: 15182412
[TBL] [Abstract][Full Text] [Related]
22. Combined creatinine velocity and nadir creatinine: A reliable predictor of renal outcome in neonatally diagnosed posterior urethral valves.
Coleman R; King T; Nicoara CD; Bader M; McCarthy L; Chandran H; Parashar K
J Pediatr Urol; 2015 Aug; 11(4):214.e1-3. PubMed ID: 26062970
[TBL] [Abstract][Full Text] [Related]
23. Long-term upper and lower urinary tract functions in children with posterior urethral valves.
Otukesh H; Sharifiaghdas F; Hoseini R; Fereshtehnejad SM; Rabiee N; Kiaiee MF; Javadi R; Mojtahedzadeh M; Simfroosh N; Basiri A; Hooman N; Nasiri J; Delshad S; Farhood P
J Pediatr Urol; 2010 Apr; 6(2):143-7. PubMed ID: 19679514
[TBL] [Abstract][Full Text] [Related]
24. Fetal surgery for posterior urethral valves: long-term postnatal outcomes.
Holmes N; Harrison MR; Baskin LS
Pediatrics; 2001 Jul; 108(1):E7. PubMed ID: 11433086
[TBL] [Abstract][Full Text] [Related]
25. Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules.
Vieira ÉLM; Pessoa Rocha N; Macedo Bastos F; da Silveira KD; Pereira AK; Araújo Oliveira E; Marques de Miranda D; Simões E Silva AC
Pediatr Nephrol; 2017 Aug; 32(8):1391-1400. PubMed ID: 28229280
[TBL] [Abstract][Full Text] [Related]
26. Progression to end-stage renal disease in children with posterior urethral valves.
Drozdz D; Drozdz M; Gretz N; Möhring K; Mehls O; Schärer K
Pediatr Nephrol; 1998 Oct; 12(8):630-6. PubMed ID: 9811384
[TBL] [Abstract][Full Text] [Related]
27. Urinary transforming growth factor-beta in patients with glomerular diseases.
Murakami K; Takemura T; Hino S; Yoshioka K
Pediatr Nephrol; 1997 Jun; 11(3):334-6. PubMed ID: 9203185
[TBL] [Abstract][Full Text] [Related]
28. Renal impairment in children with posterior urethral valves.
Kari JA; El-Desoky S; Farag YM; Mosli H; Altyieb AM; Al Sayad A; Radawi O; Ghabra H; Basnawi F; Bahrawi O; Singh A; Farsi H
Pediatr Nephrol; 2013 Jun; 28(6):927-31. PubMed ID: 23263712
[TBL] [Abstract][Full Text] [Related]
29. Proximal urinary diversion in the management of posterior urethral valves: is it necessary?
Tietjen DN; Gloor JM; Husmann DA
J Urol; 1997 Sep; 158(3 Pt 2):1008-10. PubMed ID: 9258131
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for end stage renal disease in children with posterior urethral valves.
DeFoor W; Clark C; Jackson E; Reddy P; Minevich E; Sheldon C
J Urol; 2008 Oct; 180(4 Suppl):1705-8; discussion 1708. PubMed ID: 18708224
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria.
Goumenos DS; Tsakas S; El Nahas AM; Alexandri S; Oldroyd S; Kalliakmani P; Vlachojannis JG
Nephrol Dial Transplant; 2002 Dec; 17(12):2145-52. PubMed ID: 12454225
[TBL] [Abstract][Full Text] [Related]
32. Successful renal transplantation in children with posterior urethral valves.
DeFoor W; Tackett L; Minevich E; McEnery P; Kitchens D; Reeves D; Sheldon C
J Urol; 2003 Dec; 170(6 Pt 1):2402-4. PubMed ID: 14634437
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for renal insufficiency in children with urethral valves.
Pohl M; Mentzel HJ; Vogt S; Walther M; Rönnefarth G; John U
Pediatr Nephrol; 2012 Mar; 27(3):443-50. PubMed ID: 22009479
[TBL] [Abstract][Full Text] [Related]
34. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
[TBL] [Abstract][Full Text] [Related]
35. Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period.
Goumenos DS; Tsakas S; Karavias D; Savidaki I; Karatzas T; Vlachojannis JG
Ren Fail; 2003 Jul; 25(4):561-8. PubMed ID: 12911160
[TBL] [Abstract][Full Text] [Related]
36. Increased urinary excretion of alpha1-microglobulin at 6 months after transplantation is associated with urinary excretion of transforming growth factor-beta1 and indicates poor long-term renal outcome.
Teppo AM; Honkanen E; Finne P; Törnroth T; Grönhagen-Riska C
Transplantation; 2004 Sep; 78(5):719-24. PubMed ID: 15371675
[TBL] [Abstract][Full Text] [Related]
37. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy.
Sato H; Iwano M; Akai Y; Kurioka H; Kubo A; Yamaguchi T; Hirata E; Kanauchi M; Dohi K
Am J Nephrol; 1998; 18(6):490-4. PubMed ID: 9845822
[TBL] [Abstract][Full Text] [Related]
38. [Chronic renal disease in boys with posterior urethral valve].
Maternik M; Zurowska A; Czarniak P; Drozyńska-Duklas M; Kosiak W; Gołebiewski A
Przegl Lek; 2006; 63 Suppl 3():146-8. PubMed ID: 16898515
[TBL] [Abstract][Full Text] [Related]
39. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
[TBL] [Abstract][Full Text] [Related]
40. Renal transplantation in children with posterior urethral valves.
Bryant JE; Joseph DB; Kohaut EC; Diethelm AG
J Urol; 1991 Dec; 146(6):1585-7. PubMed ID: 1942347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
